Business Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors Posted on April 2, 2024 by miyuru Author of the article: Published Apr 02, 2024 • 8 minute read Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages….
